Product Responsibility Summit 2018: Emerging Regulatory Challenges
Recorded On: 09/16/2018
As more states and countries legalize medical and recreational cannabis, where can you turn for legal and regulatory guidance related to both drug paraphernalia and marketing support for this growing market?
Emily is member of the FDA practice group in Arent Fox’s Washington D.C. office. Emily focuses her practice on a variety of highly-regulated products including prescription and over-the-counter drugs, dietary supplements, foods, alcoholic beverages, and cannabis. She counsels clients on matters affecting the cannabis industry, such as licensing and permitting requirements, labeling and promotional review, good manufacturing practices, and supply chain management. Before joining Arent Fox, Emily worked at the U.S. Food and Drug Administration for nearly six years. She has followed the legalized cannabis industry since 2004 when, while earning a master’s degree in public health policy, Emily worked with a major county health department to implement the requirements of California’s Medical Marijuana Identification Card Program. She also speaks and writes regularly on current regulatory issues facing the cannabis industry. Emily earned her JD from American University, Washington College of Law, Master of Public Policy from the University of Southern California, and BA from the University of Texas at Austin.
1. Register and watch the session. Please note it will open in a new window. Please do not close the session launch page.
2. Please make sure your pop-up blocker is turned off in order to access the session once you select it.
3. Once you have completed the session, please close the event recording or webinar window and proceed to the session launch page for the Online Education Survey to receive credit. Please note, it will not be on your event recording or webinar window.